Healthcare Cost Comparison

Selected news for the healthcare topic - Healthcare Cost Comparison, collected since 7/2019. We are still establishing shared news links for this healthcare topic.

Please provide a valid email address.
Shares Healthcare News With (link):
Other Healthcare Entities

Selected Headlines

Date Headline (link) Source Relevant Snippet
7/3/2019 Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma Monoclonal antibodies targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) (e.g., ipilimumab [IPI]) and the programmed cell death-1 (PD1) receptor (e.g., nivolumab [NIVO]) represent significant breakthroughs in the treatment of advanced melanoma. A combination of the 2 agents has demonstrated efficacy and survival benefits over NIVO or IPI monotherapy in treating advanced melanoma. We compared melanoma-specific costs following treatment with NIVO + IPI, NIVO monotherapy, or IPI monotherapy ...